Total Payments
$48,133
2022 Payments
$945.15
Companies
33
Transactions
419
Medicare Patients
3,690
Medicare Billing
$525,579
Payment Breakdown by Category
Other$35,600 (74.0%)
Food & Beverage$8,173 (17.0%)
Travel$4,085 (8.5%)
Gifts$239.65 (0.5%)
Education$36.48 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $35,600 | 12 | 74.0% |
| Food and Beverage | $8,173 | 384 | 17.0% |
| Travel and Lodging | $4,085 | 13 | 8.5% |
| Gift | $239.65 | 4 | 0.5% |
| Education | $36.48 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $29,672 | 32 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12,141 | 146 | $0 (2022) |
| ABBVIE INC. | $1,233 | 49 | $0 (2022) |
| Gilead Sciences, Inc. | $1,010 | 22 | $0 (2022) |
| Covidien LP | $525.54 | 4 | $0 (2018) |
| Braintree Laboratories, Inc. | $507.13 | 20 | $0 (2022) |
| Intercept Pharmaceuticals, Inc. | $424.53 | 8 | $0 (2021) |
| Synergy Pharmaceuticals Inc | $419.07 | 25 | $0 (2018) |
| Allergan, Inc. | $331.03 | 24 | $0 (2020) |
| Ironwood Pharmaceuticals, Inc | $271.21 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $945.15 | 67 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($257.39) |
| 2021 | $1,069 | 77 | AbbVie Inc. ($327.34) |
| 2020 | $1,182 | 53 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($319.37) |
| 2019 | $5,490 | 68 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($4,527) |
| 2018 | $8,672 | 80 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($6,757) |
| 2017 | $30,775 | 74 | Valeant Pharmaceuticals North America LLC ($29,672) |
All Payment Transactions
419 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $5.02 | General |
| Category: Gastroenterology | ||||||
| 12/15/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.80 | General |
| Category: GI | ||||||
| 12/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Gastroenterology | ||||||
| 11/28/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: VIROLOGY | ||||||
| 11/23/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Gastroenterology | ||||||
| 11/10/2022 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: Gastroenterology | ||||||
| 11/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: Gastroenterology | ||||||
| 11/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: Gastroenterology | ||||||
| 10/27/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Gastroenterology | ||||||
| 10/21/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/06/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: GI COLON PREP | ||||||
| 10/05/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: Gastroenterology | ||||||
| 09/22/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Immunology | ||||||
| 09/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: Gastroenterology | ||||||
| 09/15/2022 | Ferring Pharmaceuticals Inc. | CIMZIA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/14/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: Gastroenterology | ||||||
| 09/14/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: Gastroenterology | ||||||
| 09/02/2022 | FUJIFILM Healthcare Americas Corporation | UTASWAKO AFP-L3 (Device) | Food and Beverage | In-kind items and services | $34.58 | General |
| Category: Medical Device | ||||||
| 08/31/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Gastroenterology | ||||||
| 08/25/2022 | PENTAX of America, Inc. | — | Food and Beverage | Cash or cash equivalent | $29.50 | General |
| 08/18/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/17/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: Gastroenterology | ||||||
| 08/17/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: Gastroenterology | ||||||
| 08/08/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 16 | 1,183 | 1,611 | $453,651 | $168,161 |
| 2021 | 13 | 1,145 | 1,728 | $452,330 | $178,287 |
| 2020 | 16 | 1,362 | 1,979 | $487,153 | $179,132 |
Total Patients
3,690
Total Services
5,318
Medicare Billing
$525,579
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 528 | 923 | $147,953 | $78,605 | 53.1% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2022 | 83 | 83 | $75,032 | $16,893 | 22.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 113 | 134 | $26,800 | $16,040 | 59.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 114 | 120 | $55,560 | $11,563 | 20.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 55 | 55 | $35,365 | $9,909 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $15,369 | $7,284 | 47.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 40 | 40 | $25,720 | $7,217 | 28.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 42 | 42 | $10,369 | $6,020 | 58.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 40 | 41 | $27,593 | $4,715 | 17.1% |
| 43270 | Destruction of polyp or growth of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 15 | $12,795 | $2,492 | 19.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $7,073 | $1,583 | 22.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $7,174 | $1,576 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 23 | $2,300 | $1,441 | 62.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $1,740 | $1,154 | 66.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $1,800 | $975.47 | 54.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 14 | $1,008 | $692.09 | 68.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 571 | 1,120 | $166,448 | $95,825 | 57.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 102 | 119 | $22,365 | $15,598 | 69.7% |
| 45388 | Destruction of tissue abnormalities, tumors, or polyps of large bowel using a flexible endoscope | Facility | 2021 | 66 | 69 | $62,376 | $14,171 | 22.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 126 | 129 | $59,727 | $13,354 | 22.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 57 | 57 | $36,651 | $10,421 | 28.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 82 | 82 | $16,769 | $9,256 | 55.2% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 46 | 48 | $32,304 | $5,036 | 15.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 25 | 25 | $16,075 | $4,579 | 28.5% |
| 43270 | Destruction of growths on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 11 | 20 | $17,060 | $3,211 | 18.8% |
About Dr. Michael Dohrenwend, MD
Dr. Michael Dohrenwend, MD is a Gastroenterology healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922089598.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Dohrenwend, MD has received a total of $48,133 in payments from pharmaceutical and medical device companies, with $945.15 received in 2022. These payments were reported across 419 transactions from 33 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($35,600).
As a Medicare-enrolled provider, Dohrenwend has provided services to 3,690 Medicare beneficiaries, totaling 5,318 services with total Medicare billing of $525,579. Data is available for 3 years (2020–2022), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Huntsville, AL
- Active Since 11/09/2005
- Last Updated 12/07/2009
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922089598
Products in Payments
- XIFAXAN (Drug) $21,288
- RELISTOR (Drug) $12,037
- APRISO (Drug) $3,929
- UCERIS (Drug) $3,645
- TRULANCE (Drug) $794.39
- Epclusa (Drug) $564.50
- LINZESS (Drug) $510.65
- MAVYRET (Drug) $430.91
- OCALIVA (Drug) $424.53
- Trulance (Drug) $419.07
- Mavyret (Drug) $334.75
- Barrx (Device) $265.65
- SUPREP BOWEL PREP (Drug) $263.84
- Linzess (Drug) $219.87
- INJECTAFER (Drug) $186.43
- Amitiza (Drug) $177.69
- LINX Reflux Management System (Device) $140.49
- SUTAB (Drug) $136.57
- VIBERZI (Drug) $121.26
- SUPREP (Drug) $106.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Huntsville
John-Paul Voelkel, M.d, M.D
Gastroenterology — Payments: $17,351
Gastroenterology $17,351
Meredith Roath, M.d, M.D
Gastroenterology — Payments: $16,777
Gastroenterology $16,777
Charles Billings, Md, MD
Gastroenterology — Payments: $16,031
Gastroenterology $16,031
Dino Ferrante, Md, MD
Gastroenterology — Payments: $15,843
Gastroenterology $15,843
Mark Moglowsky, Md, MD
Gastroenterology — Payments: $12,186
Gastroenterology $12,186
Suresh Karne, Md Phd, MD PHD
Gastroenterology — Payments: $11,520
Gastroenterology $11,520